To this end, the increased expression of VCAM-1 either within the kidneys or in the urine has already been documented previously in patients with ANCA-GN, FSGS and membranous nephropathy, in resonance with our findings [33-36]. This evidence concerns the gene VCAM1 and membranous glomerulonephritis.